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N-Telopeptide (NTx) of Type I Collagen:
A Biochemical Tool for Assessing Bone
Turnover
Drs Aysha Habib Khan, Farhan Javed Dar
Chemical Pathology
Bone undergoes continuous remodeling as it is a
dynamic structure. Bone remodeling can be
assessed by the use of bone turnover markers.
Depending upon the state of bone they can be
categorized into bone formation and bone
resorption markers. Markers of bone resorption
seemed to be stronger predictors of future bone
loss than markers of bone formation. Out of these,
a bone resorption marker, cross-linked
N-Telopeptides of type I collagen (NTx) provides a
valuable tool for assessing Bone Turnover.
Approximately 90% of the organic matrix of
mammalian bone consists of type I collagen that is
cross-linked at the N-terminal and C-terminal ends.
This highly cross-linked structure provides the basic
fabric and tensile strength to the bone tissue. NTx
represents the N-terminal cross link and is specific to
bone and is found in serum and urine as a stable end
product of bone degradation. An elevated NTx level
correlates with high bone turnover.
Experimental and clinical studies have
demonstrated that markers of bone turnover may
reflect changes in bone metabolism induced by
oophorectomy, hyperparathyroidism, Paget's
disease, physical exercise, immobilization,
alcoholism, smoking, vitamin D deficiency, chronic
inflammatory bowel disease, chronic starvation,
thyroid disorders as well as pharmacological effects
of glucocorticoids, androgens, gonadotropin
releasing hormone agonists, warfarin, growth
hormone or insulin like growth factors. However, in
most of these conditions there role has not been
rigorously examined.
Using biochemical markers like NTx, it may be
possible to identify those subjects who lose bone
rapidly and are likely to develop osteoporosis and
future fractures. However, its main role is in
monitoring the therapeutic response. Although
2

DEXA scan is still the best way to judge the changes
in bone mineral density in osteoporosis, the bone
mass changes takes 1-2 years to become apparent
on DEXA scan. With NTx patients can be monitored
as early as 3 to 6 months after starting therapy for
osteoporosis. A baseline NTx level should be
measured in all patients before beginning antiresorptive therapy. If treatment is stopped, NTx
levels tend to return slowly to the pre-treatment
baseline, which makes it a useful monitoring tool for
poor compliance. For monitoring purpose it is
advised to collect sequential samples at
approximately the same time of day.
Sources of variability in bone resorption markers
include circadian rhythm, fluctuations in renal
function, and dietary calcium intake. Serum based
markers of bone turnover tend to show less
variability as compared with urine based markers.
Measurement of NTx in serum offer bone resorption
testing with decreased intrasubject variability.
NTx levels are now measured in the Clinical
Laboratory of Aga Khan University Hospital using
serum by ELISA technique.

Automated Blood Grouping
Dr Nausheen Kamran
Resident, Haematology
Blood banks and transfusion services are the last
areas of the clinical laboratory to move to
automation. Chemistry, Haematology and
Immunology have been using automation for many
years, but blood services have been hampered by
the complexity of testing and subjectivity of the test
interpretation.
In recent years, new pressure has been applied to
this area of laboratory. Personnel shortages,
turnaround time and the need for cost containment
produced by increased managed care have
provided the incentive for blood services to seek
automation.
By using walk-away automation, lab personnel are
able to perform multiple tasks simultaneously.
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Automated equipment also provides the level of
quality assurance required by new regulatory
standards. Standardized techniques reduce testing
errors.
In 1985 the gel test was developed by Dr Yves
Lapierre of Lyon, France. Various media including
gelatin, acrylamide gel and glass beads were
investigated in an attempt to trap agglutinates during
a standardized sedimentation or centrifugation step.
The gel test, which is performed in a specially
designed micro tube, is based on the controlled
centrifugation of RBCs through a dextranacrylamide
gel that contains predispensed reagents. Each micro
tube is composed of an upper reaction chamber that
is wider than the tube itself and a long, narrow
portion referred to as the column. In the gel test
plastic cards with micro tubes are used instead of
test tubes. The gel particles are porous and they
serve as a reaction medium and filter. Large
agglutinates are trapped at the top of the gel and are
not allowed to travel through the gel during the
centrifugation of the card. The unagglutinated RBCs
travel unimpeded through the length of the micro
tube forming a pellet at the bottom following
centrifugation.
Blood samples should be drawn in citrate, EDTA or
CPD-A anticoagulant. A gel card is approximately
5x7 centimeters and consists of six micro tubes
(Figure 1). The ABO blood grouping cards contains
gel that include blood group specific reagent, e.g.,
anti-A, anti- B, and anti-A, B for forward grouping.
Microtubes with buffered gel are used for ABO
reverse grouping. Pipette 25 l of the patient's red
cell suspension to the first 3 micro tubes of the ID
card. Centrifuge the ID cards for minutes in the
centrifuge.

the gel column, with few agglutinates staggered
below thicker band.
A 2+ reaction
agglutinated RBCs dispersed
throughout the gel column.
A 1+ reaction
agglutinated RBCs predominantly
in the lower half of the gel column.
Negative reaction
RBCs form a well delineated
pellet at the bottom of the micro tube.
Known positive and negative samples should be
included as controls.

Figure 1: Diamed ID Gel Station

Advantages of automated red cell typing:
Standardization: there is no tube shaking to resuspend the RBC button
! It provides stable end point of the agglutination
reaction
! Results can be interpreted even after hours
! Results can be photographed
! Decreased sample volume required for testing
! One card can be used for two samples
!

Disadvantages:
! Purchase of special incubators and centrifuges
to accommodate micro tube cards
! Special pipettes are required

Read and record the result. Agglutination reaction in
the gel is graded from 1+ to 4+ (including mixed
field). The reactions are read as:
A 4 + reaction
solid band of agglutinated RBCs at
the top of the gel.
A 3 + reaction
agglutinated RBCs near the top of

Figure 2: Gel Card showing
AB positive blood group

Figure 3: Gel card showing
O positive blood group
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Leukocyte Alkaline Phosphatase
(LAP Score)
Ms Mashhooda Rasool Hashmi
Senior Technologist, Haematology
Alkaline phosphatase activity is found
predominantly in mature neutrophils, with some
activity in metamyelocytes. Normally about 2% of
the mature granulocytes give a positive alkaline
phosphatase reaction. Although demonstrated as a
granular reaction product in the cytoplasm, enzyme
activity is associated with a poorly characterized
intra cytoplasmic membranous component distinct
from primary and secondary granules. Other
leukocytes are generally negative, but rare cases of
lymphoid malignancies show cytochemical
demonstrable activity. Bone marrow macrophages
are positive.

with coarse granules filling the cytoplasm and
overlying the nucleus. An overall score is obtained
by assessing the staining intensity in 100
consecutive neutrophils, with each neutrophil
scored on a scale of 1 to 4 as follows:
0 = negative, no granules
1 = occasional granules scattered in the cytoplasm
2 = moderate number of granules
3 = numerous granules
4 = heavy positivity with numerous coarse granules
crowding the cytoplasm, frequently
overlying the nucleus

In 1929, Kay first suggested the presence of alkaline
phosphatase in leukocytes. However, not until
many years later did Kaplow introduce a practical
staining method for demonstrating the leukocyte
enzyme.
The substrate, naphthol AS-B1 phosphate is
hydrolysed to phosphate and aryl naphtholamide by
alkaline phosphatase. The aryl naphtholamide is
coupled to the diazonium salt, fast blue RR forming
an insoluble dye.
Blood films prepared from capillary blood or
heparinized venous blood may be used. Blood
smears should be stained for enzyme activity within
eight hours after preparation. It is preferable to stain
the smears immediately, however, fixed smears may
be held at freezing temperature for two to three
weeks with loss of only approximately 10% of
activity. Films should be dried one hour prior to
fixation and three hours post-fixation before
freezing.
The reaction product is blue/brown and granular
(Figure 1). The intensity of reaction product in
neutrophils varies from negative to strongly positive,
4

Figure 1: Neutrophil with numerous blue/brown granules.

The normal range of LAP score is 32 to 182. In
normal individuals, it is rare to find neutrophils with
scores of 3, and scores of 4 should not be present.
There is some physiological variation in LAP score.

Figure 2: Neutrophils in CML showing no granules. A single neutrophil
(marked by arrow) contains moderate number of granules.
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Newborn babies, children and pregnant women
have high scores, and premenopausal women have,
on average, scores one third higher than men. In
pathological states, the most significant diagnostic
use of LAP score is in chronic myeloid leukemia. In
the chronic phase of disease, the score is almost
invariably low; usually zero (Figure 2). In myeloid
blast transformation or accelerated phase, the score
rises. Transient rises may occur with intercurrent
infection. Raised LAP score can also be encountered
in polycythemia rubra vera, leukamoid reaction and
Hodgkin's disease.
Low scores are also found in paroxysmal nocturnal
hemoglobinuria and hereditary hypophosphatasia.

Pathology Quiz
Dr Lena Jafri
Resident, Chemical Pathology
A 17-year old female with short stature but no
dysmorphic features was referred to AKUH
laboratory for growth hormone deficiency
evaluation. She came with proper 12 hours of
fasting. Two-hour growth hormone insulin test was
performed and the results obtained were as follows:
Glucose (mg/dl)
Fasting:
84
At 30min:
26
At 45min:
48
At 60min:
56
At 90min:
68
At 120min: 76

Growth hormone (ng/ml)
19.1
12.7
14.4
16.7
22.1
59.7

Synovial Fluid Analysis in Important
Joint Diseases
Dr Raihan Sajid
Assistant Professor, Haematology
Synovial fluid is believed to be produced by dialysis
of plasma across the synovial membrane and by
secretion of hyaluronate-protein complex by the
synovial membrane. Synovial membrane lines
joints, bursae, synovial tendon sheaths, but not the
articular cartilages and menisci. The function of
synovial fluid is lubrication and nourishment of the
articular cartilage.
Inflammation of the synovial membrane will cause
leakiness of synovial membrane and influx of WBC
and exudation of proteins into synovial fluid. Any
joint can be aspirated, however joint aspiration
should be performed by an experienced operator
under sterilized conditions.
Synovial fluid analysis comprises of appearance,
viscosity, protein, glucose, and TLC, DLC and
crystals identification under polarized light.
Additional tests include lactate, uric acid, pH
measurements and immunologic studies including
rheumatoid factor, ANA antibodies and
complement measurements. Gram stain and
cultures should always be sent if septic arthritis is
suspected. In rheumatoid arthritis in about 95% of
patient's cells known as RA cells are present which
contain small, dark cytoplasmic granules from 0.5 to
2 diameters within 5-100% of neutrophils.

Questions:
1. Are these results normal?
2. Which clinical syndrome did the patient have?
3. Where does the defect lie?
4. What other tests will you order to confirm your
diagnosis?
5. What therapy is recommended for such
children?

Normal synovial fluid is crystal clear and pale
yellow in colour. It has high viscosity with WBC less
than 200/cumm, protein less than 2 gm/dl and
glucose nearly equal to blood levels. Milky fluid
may occur with tuberculosis, chronic rheumatoid
arthritis and SLE and calcium hydroxyapatite
arthropathy. In rheumatoid arthritis the appearance
of the synovial fluid shall be turbid with low
viscosity, a high WBC count of more than
20,000/cumm with 70% neutrophils and RA cells
are usually present.

Answers on page 8

In septic arthritis, the appearance of the synovial
5
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fluid will be turbid to purulent with low viscosity,
high WBC count of 90,000/cumm with more than
90% neutrophils. Gram stain and culture is positive
in about 50% of the patients with septic arthritis. In
osteoarthritis the appearance of synovial fluid is
usually clear yellow, leukocyte count of 700/cumm
with 15% neutrophils and collagen fibrils and/or
cartilage fragments are usually present.

Figure 1: Crystals under polarized light.

Intraductal Papillary Mucinous Tumor
(IPMT) of the Pancreas:
A Diagnostic Challenge
Drs Zishan Haider*, Ishtiaq Chishti*, Farhan
Ahmed**, Dawar Khan*; *Assistant Professor,
** Senior Instructor, Radiology
Primary cystic pancreatic neoplasms are rare
tumors, with an approximate prevalence of 10% of
cystic pancreatic lesions. The natural history of
intra-ductal papillary mucinous tumours of the
pancreas (IPMTs) is unknown. In clinical practice
the signs and symptoms are non-specific. Diagnosis
is usually not easy without using new imaging
modalities such as CT or MRI. Considering number
of cystic lesions of pancreas, diagnosis of pancreatic
IPMT is usually challenging as it is relatively newer
diagnostic entity. Multidetector CT is helpful in the
preoperative differentiation of malignant and
benign pancreatic IPMT. Definitive diagnosis is
often possible when the lesions show typical
radiologic appearances (Figures 1 and 2).

Figure 1 shows crystals under polarized light.
Table 1 shows categories of synovial fluid based on
clinical and laboratory findings.
Table 1: Categories of synovial fluid based
upon clinical and laboratory findings.
Categories of Synovia Fluid Based Upon Clinical and Laboratory Finding
Measure

Noninflammatory Inflammatory Septic

Hemorrhagic

Volume, mL (knee) <3.5

Normal

Often >3.5

Often >3.5

Often >3.5

Usually >3.5

Clarity

Transparent

Transparent

Translucentopaque

Opaque

Bloody

Color

Clear

Yellow

Yellow to
Opalescent

Yellow to
green

Red

Viscosity

High

High

Low

Variable

Variable

WBC, per mm3

<200

200-2,000

2,000-10,000

>100,000

200-2,000

PMNs, percent

<25

<25

>50

>75

50-75

Culture

Negative

Negative

Negative

Often positive

Negative

Total protein, g/dL 1-2

1-3

3-5

3-5

4-6

LDH (compared to Very low
levels in blood)

Very low

High

Variable

Similar

Glucose, mg/dL

Nearly equal Nearly equal
>25, lower
>25,much lower Nearly equal
to blood
to blood
than blood
than blood
to blood
Lower with infections caused by partially treated or low virulence organisms

References:
1. Clinical Diagnosis and Management by
Laboratory Methods, 17th edition. John Bernard
Henry. Pages 475-83.
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Figure 1: Atrophic pancreas with tortuous cystic dilatation of
pancreatic duct on axial contrast enhanced CT scan.

IPMT of the pancreas can be divided into three
clinically distinct sub-types: main duct type, branch
duct type and mixed type. IPMT is characterized by
diffuse dilatation of the main pancreatic duct and/or
side branches with inner defects related to mucin or
tumor, or mucin extrusion from a patent ampulla.
IPMT has a low potential for malignancy, with a low
growth rate, a low rate of metastatic spread and
postsurgical recurrence. Over the last few years,
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major advances have been made in the diagnostic
and therapeutic management of this tumor.
The presence of a dilated main pancreatic duct,
mural nodules, thickened wall and peripancreatic
haziness can be predictive signs of malignancy.
Although it has been reported that the branch duct
type IPMT is less invasive than the main duct type
IPMT, some times branch duct type IPMT may have
poor prognosis.
The use of CT scan with high-resolution MPR images
significantly improves diagnostic performance for
demonstrating connection between pancreatic
cystic lesions and the main pancreatic duct, which is
useful for the diagnosis of branch duct-type IPMT. If
prompt diagnosis is established then it can improve
patient care and optimal surgical treatment can be
planned.

Figure 2: Same patient in coronal enhanced CT slice showing
normal caliber of CBD with dilated tortuous duct containing subtle
high density material suggestive of IPMT.

References:
1. Taouli B, Vilgrain V, Vullierme MP, Terris B,
Denys A, Sauvanet A, Hammel P, Menu
Y. Intraductal papillary mucinous tumors of the
pancreas: helical CT with histopathologic
correlation. Radiology 2000; 217:757764
2. Lim JH, Lee G, Oh YL. Radiologic spectrum of
intraductal papillary mucinous tumor of the
pancreas. Radio-Graphics 2001; 21(2):323337.
3. De Lima JE Jr, Javitt MC, Mathur SC.
Mucinouscystic neoplasm of the pancreas.
Radio-Graphics 1999; 19(3):807811.

Hepatitis Delta Virus (HDV)
Ms Hina Noureen,
Assistant Technologist, Molecular Pathology
Hepatitis D virus (HDV, also called the delta virus) is
a defective pathogen and considered to be a subviral satellite because it can propagate only in the
presence of hepatitis B virus. Transmission of HDV
can occur either via simultaneous infection with
HBV (co-infection) or via infection of an individual
previously infected with HBV (super infection). The
delta antigen was first detected by an Italian
physician Mario Tizzetto in hepatocytye of patients
with chronic type B hepatitis.
Genetic Structure of HDV
This is a 36 nm virus with a 1.7 kb circular negative
strand RNA genome which is folded as a rod like
structure. It has approximately 1,700 nucleotides,
the smallest genome of all known human
pathogens. The HDV virion is composed of an outer
lipoprotein envelope made of the surface antigen of
HBV (HBsAg) and an inner ribo-nucleoprotein
structure in which the HDV genome reside. The
nucleo-capsid consists of a smaller HD Ag-S and a
large HD Ag-L peptide which play different
biological roles in the viral life cycle. HD Ag-S is
produced in the early stages of an infection and is
required for viral replication. HD Ag-L, is in
contrast, is produced during the later stages of an
infection, acts as an inhibitor of viral replication and
is required for assembly of viral particle.
Symptoms
Co-infection (acute):
Patients infected with HBV and HDV
simultaneously suffers from fatigue, lethargy,
anorexia, nausea, headache, jaundice. Incubation
period is 3 to 7 weeks.
Super Infection
Post-infected with HBV and later infected with HDV
suffers from jaundice, hepatic encephalopathy,
changes in personality, coagulopathy, disturbance
in sleep, and confusion, and acute massive
destruction of large portion of liver.
7
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Chronic Infection
Similar symptoms to above but severe ongoing liver
inflammation, cirrhosis leads to liver failure, death
from bleeding, hepatic infection and kidney failure.
Diagnosis of HDV
Diagnosis is done primarily by serological assays
and PCR. Due to the dependence of HDV on HBV,
the presence of HBsAg is necessary for the diagnosis
of HDV infection. The additional presence of IgM
antibody to hepatitis B core antigen (IgM anti-HBc)
is necessary of diagnosis of acute HBV/HDV
coinfection. High levels of IgM and IgG anti-HD are
associated with progression to chronicity.
HDV RNA is extracted using High Pure Viral RNA kit
(Roche, USA) then cDNA is synthesized and
amplified by RT- PCR. The PCR product is run on the
gel electrophoresis which gives picture of bands
indicating (L) ladder, i.e. reference dye, positive
control, negative control (not shown in the figure
below), and positive patient's (Pt) sample.

Treatment
There is no effective antiviral therapy available for
treatment of acute or chronic type D hepatitis. Liver
transplantation has been helpful for treating
fulminant acute and end- stage chronic hepatitis.

Answers to Pathology Quiz
1. No. Growth hormone levels are abnormally
high.

L

PC

NC

Pt.

2. Laron's Syndrome. Some children with
idiopathic short stature show very high levels of
growth hormone during growth hormone
insulin test. It is not an uncommon condition. It
is a familial disorder with an autosomal
recessive form of inheritance. Laron and his
colleagues were the first to describe short stature
with characteristic features of isolated growth
hormone deficiency but with elevated growth
hormone levels. It is also known as growth
hormone insensitivity syndrome.
3. The fault lies in the inability of the growth
hormone target cells to respond to growth
hormone due to defective growth hormone
receptor on cell surface.

Transmission
Blood borne, sexual, percutaneous, permucosal and
rarely perinatal.

4. Serum assays for insulin-like growth factor 1(IGF-1) and insulin growth factor binding
protein -3 are now commercially available.
Patients with Laron's syndrome have normal or
elevated circulating growth hormone but low
IGF-1 and low IGFBP-1. They should be
included in complete evaluation of such
patients but unfortunately these tests are not
available in our laboratory at present.

Prevention
Abstinence from alcohol, Percutaneous of personal
contact with HBV infected Patients is
recommended. The vaccine against hepatitis B also
prevents delta hepatitis.

5. Effects of recombinant human IGF-1 on linear
growth of children with receptor mutations have
proven beneficial and it has been recommended
as a long term therapy for patients with Laron's
Syndrome.

Figure 1: Different stages of the epilome enzyne
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Thyroid Autoimmune Diseases and
Thyroid Peroxidase (TPO) Antibody
Dr Sahar Iqbal
Resident, Chemical Pathology
The autoimmune diseases are the frequent causes of
thyroid disorders. Important targets for auto
antibodies are thyroid receptors (TSHR),
thyroglobulin (Tg) and thyroid peroxidase (TPO). In
up to 90% of autoimmune thyroid disease thyroid
peroxidase antibody (TPO-Ab) are seen, whereas
anti thyroglobulin(Tg-Ab) is found in less than 20%
of the cases. TSH receptors antibodies (TSHR-Ab)
are specific for Graves' disease, in contrast to Tg-Ab
and TPO-Ab. Almost all patients with Graves'
hyperthyroidism have detectable TSHR-Ab when
measured by sensitive assays.
TPO is a glycoprotein present as a dimer on the
apical surface of thyroid follicular cells as well as in
cytoplasm. It catalyses the thyroid hormone
synthesis and thought to represent the cell surface
antigen involved in cell mediated cytotoxicity. TPOAb inhibits TPO enzyme activity, resulting in
decrease synthesis of thyroid hormones.
Measurement of TPO-Ab is important in the
diagnosis of autoimmune thyroid diseases
especially Hashimoto's thyroiditis. Prevalence of
TPO-Ab is also found to be high in other
autoimmune disorders and many studies have
shown the association of presence of TPO-Ab with
other diseases including pernicious anaemia,
diabetes mellitus, poly cystic ovarian syndrome,
urticaria and arthritis.
In relation to pregnancy the presence of thyroid
autoimmunity, appears to be a determining factor in
future pregnancy loss, not only in hypo-and
hyperthyroid women but also in euthyroid ones. In
the early 1990s it was discovered that unselected
euthyroid women who present with thyroid
antibodies to TPO and Tg in the early trimesters of
pregnancy have a two-to-four-fold increase in their
miscarriage rates.

The prevalence of TPO-Ab among pregnant women
is 10-12% in different studies.
Many other studies showed high prevalence of TPOAb positive results in pregnant women and its
association with adverse outcomes including
miscarriage or abortion, preterm delivery, low birth
weight, postpartum thyroiditis. Hypothyroidism
during pregnancy may lead to the impaired
neuropsychological development of the child.
In our laboratory both TPO-Ab and Tg-Ab are
performed by Microparticle enzyme immunoassay
(MEIA) for detection of thyroid autoimmune
disease.

Therapeutic Monitoring of Tacrolimus
Ms Noureen Niaz Ali
Staff Technologist, Chemical Pathology
Tacrolimus is an immunosuppressive drug which
was discovered during routine screening and
fermentation of streptomyces tsukubaensis fungi. It
is also known as FK 506. After its discovery, it was
soon recognized that tacrolimus effectively
suppresses and prevents organ graft rejection by
inhibiting the early events in T cells activation and
proliferation by suppression of IL-2 and other
cytokines transcription.
Therapeutic monitoring of blood level of tacrolimus
is required for effective and safe use because its
therapeutic window is narrow and its toxic effect
correlates with whole blood levels. In addition, it
produces renal vasoconstriction and hypertension.
It is also diabetogenic and is capable of causing
central nervous system toxicity.
Several methods have been developed to measure
tacrolimus (FK506). In AKUH laboratory, we use
IMX (instrument) which works on microparticle
enzyme immunoassay technology (MEIA) requiring
monoclonal antibody. Whole blood is the preferred
sample for the measurement of tacrolimus levels.
EDTA is the preferred anticoagulant. False positive
results can occur when blood sample of patient clots
in the tube.
9
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Meeting Report: 32nd Annual Conference
of Pakistan Association of Pathologists
Reported by Dr Lena Jafri
Resident, Chemical Pathology
The 32nd annual conference of Pakistan Association
of Pathologists (PAP) was held from October 24 to
26, 2008 at Abbottabad, the City of Pines. The
conference was hosted by Ayub Medical College
away from the hustle and bustle of city life.
Pathologists and scientists from all over Pakistan
were invited for a positive and interactive learning
forum.
The inaugural session was marked by a welcome
address by Professor Syed Humayun Shah, Chief
Patron PAP Conference on October 24. This was
followed by a plenary lecture by Dr Lubna Naseem
from the Pakistan Institute of Medical Sciences,
Islamabad on 'Blood Transfusion Practices: Past,
Present and Future'. The key aspect of her discussion
was better and safe transfusion practices. It was an
informative and insightful talk highlighting the risk
of transfusion-transmissible infections as a result of
poor blood donor recruitment and selection
practices and the use of untested units of blood.

AKU delegates at 32nd PAP Conference held at Abbottabad.
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The conference had two half-day free papers
interactive sessions in different disciplines of
Pathology. Participants shared their researches with
the audience. It provided an opportunity for the
participants to give presentations to their peers in
their areas of expertise. Many questions were
elicited which made for great discussion among all.
The evening grand finale culminated with a Banquet
dinner followed by a vibrant cultural evening.
Day 2 commenced with the 'State of the Art Lecture'
delivered by renowned Professor Anwar ul Haque
from Pakistan Institute of Medical Sciences,
Islamabad. His prolific talk was on 'Giant Cell
Tumor of Bone: Is it a Neoplasm?'
An inspirational Plenary Session by Dr Farooq
Ghani, Associate Professor and Consultant
Chemical Pathologist Aga Khan University, Karachi
was delivered on 'Cardiac Markers Update'. The
utility of Brain Natriuretic Peptide (BNP),
myeloperoxidase and myoglobin as evolving
cardiac markers were emphasized. This was
followed by free paper session. Numerable
scientific posters were displayed which portrayed
research advances in the field of pathology.
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AKU Clinical Laboratory Continuing
Medical Education (CME)
Seminar in Bahawalpur
Reported by Dr Romena Qazi
Assistant Professor, Molecular Biology

Dr Farooq Ghani receiving a shield from the Chief Guest
following his Plenary Lecture at PAP 2008.

Exhibition of latest equipments with the most
modern technologies was arranged for
demonstration. Professional attention was offered
on most of the booths for interested participants. The
evening was marked by the closing ceremony
addressed by Professor Jamil A. Mirza, President
PAP. Post-conference tour to scenic Nathiagali and
Ayubia was offered to the participants on the third
day of the conference.
The attendees were remarkably diverse, with high
level of enthusiasm. Whatever their field of
expertise, attendees left with valuable information.
The goal of providing a forum of information
exchange among health professionals was
successfully achieved. It was an inspirational
weekend!

From left to right:
Drs Farhan Dar and Lena Jafri, Ms Sadia Tabassum, Dr Raihan.

The CME Seminar was held at Quaid-e-Azam
Medical College (QMC), Bahawalpur on October
14, 2008 and covered a broad range of topics on
infectious and genetic diseases. It was well attended
by health care professionals as well as students, staff
and faculty members from local area hospitals and
academic institutions. Professor Dr Mazhar-ul-Haq
Attiq, Principal of the College, presided over the
session.

Dr Usman Shaikh receiving his shield from the Chief Guest.

In his opening statement, Dr Asghar Javed, Staff
Pathologist from Multan shared the mission of
AKUH Clinical Laboratory of conducting such
seminars and underscoring the role of AKUH
pathologists in educating as well as providing highquality diagnostic services for physicians and
hospitals nationwide. He invited the Chief Guest for
his welcome remarks.
Professor Mazhar-ul-Haq Attiq applauded the effort
and initiative of AKU pathologists in terms of
disseminating knowledge and sharing their
experiences with health care professionals in other
parts of the country. He further highlighted the role
of these seminars in educating the students and staff
11
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of academic institutions. He appreciated the fact
that AKUH clinical laboratory has opened hundreds
of collection points throughout the country to help
those who do not have direct access to high-quality
diagnostic facilities in their respective areas.

treatment for hepatitis-B virus (HBV). He presented
a video clip of the HBV infectious cycle, and
compared the response of different drugs used for
treating HBV infected individuals.
Dr Usman Sheikh, Assistant Professor and
Consultant Haematologist impressed the audience
with a lucid and engaging presentation on
Thalessemia. He referred to data obtained by the
AKUH clinical laboratory as well as scans to reveal
the true picture of thalessemias within the country.
He emphasized early diagnosis of thalessemia and
counseling of parents.

Dr Qazi Masroor receiving his shield from the Chief Guest.

After the welcome address Professor Mazhar-ul-Haq
Attiq delivered a seminar on Hepatitis-C Virus
(HCV) in which he presented epidemiology of HCV
in Pakistan with special emphasis on data gathered
locally to show its rising burden of disease in
Bahawalpur and its vicinity.

The last talk was delivered by Dr Romena Qazi,
Assistant Professor and Consultant Molecular
Pathologist at AKUH. She imparted essential
information about the Human Immunodeficiency
Virus (HIV) to her audience, in which she
highlighted the importance of viral genotype as well
as load in patient's treatment and management. She
discussed the various commercially available tests
for detecting and also emphasized that HIV is an
emerging public health problem which can be
curtailed through mass education. Dr Asghar Javed
closed the meeting with a vote of thanks.

Dr Aysha Habib Khan, Assistant Professor Chemical
Pathology at AKU provided an overview of the
various metabolic bone diseases. She emphasized
the important role of vitamin-D in the pathogenesis
of two common bone diseases, osteomalacia and
osteoporosis. She shared her data gathered on
ambulatory care patients and healthy asymptomatic
adults from Karachi, showing high prevalence of
vitamin-D deficiency.
Dr Qazi Masroor Ali, Associate Professor of
Medicine at QMC talked very passionately about
the epidemiology, treatment and duration of
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